BREASTChoice决策辅助工具随机对照试验
该随机对照试验评估基于网络的乳房重建决策辅助工具BREASTChoice。120例0-III期乳腺癌考虑乳房切除后重建的患者随机分入BREASTChoice组或强化常规护理组。结果显示BREASTChoice组知识得分更高(84.6% vs 58.2%正确,P<0.001),理解信心更高,但决策冲突等无差异。
要点
- BREASTChoice可提高患者对乳房重建的知识水平
- BREASTChoice提升患者理解重建信息的信心
- BREASTChoice未改变决策冲突、决策质量或咨询时长
核心结论
- BREASTChoice通过提高患者知识和提供个性化风险估计来改善乳房重建决策质量。
研究设计与样本
- 随机对照试验,纳入120例0-III期乳腺癌考虑乳房切除后重建且无既往重建的成年女性,随机分入BREASTChoice组或强化常规护理组。
主要发现
- 控制健康素养和就诊医生后,BREASTChoice组知识正确率高于强化常规护理组(84.6% vs 58.2%,P<0.001)。
- BREASTChoice组更可能知道重建通常需要超过1次手术、延迟重建降低风险、植入物可能需随时间更换(所有P<0.002)。
- BREASTChoice组理解重建信息信心更高(P=0.009)。
- 两组在决策冲突、决策过程质量、共享决策、生活质量或偏好上无差异(所有P>0.05)。
- 两组咨询时长无差异(平均29.7 vs 30.0分钟,P>0.05),BREASTChoice可用性高(平均6.3/7),完成约需27分钟。
临床怎么用
- BREASTChoice可作为术前决策辅助工具,用于提高乳腺癌患者对乳房重建的知识和理解信心。
局限性
- 需要更多研究促进即时决策支持并检验BREASTChoice对患者决策的长期影响。
- 样本以非西班牙裔白人(86.3%)和大学学历(64.3%)为主,可能限制普适性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate a web-based breast reconstruction decision aid, BREASTChoice. SUMMARY AND BACKGROUND DATA: Although postmastectomy breast reconstruction can restore quality of life and body image, its morbidity remains substantial. Many patients lack adequate knowledge to make informed choices. Decisions are often discordant with patients' preferences. METHODS: Adult women with stages 0-III breast cancer considering postmastectomy breast reconstruction with no previous reconstruction were randomized to BREASTChoice or enhanced usual care (EUC). RESULTS: Three hundred seventy-six patients were screened; 120 of 172 (69.8%) eligible patients enrolled. Mean age = 50.7 years (range 25-77). Most were Non-Hispanic White (86.3%) and had a college degree (64.3%). Controlling for health literacy and provider seen, BREASTChoice users had higher knowledge than those in EUC (84.6% vs. 58.2% questions correct; P < 0.001). Those using BREASTChoice were more likely to know that reconstruction typically requires more than 1 surgery, delayed reconstruction lowers one's risk, and implants may need replacement over time (all ps < 0.002). BREASTChoice compared to EUC participants also felt more confident understanding reconstruction information (P = 0.009). There were no differences between groups in decisional conflict, decision process quality, shared decision-making, quality of life, or preferences (all ps > 0.05). There were no differences in consultation length between BREASTChoice and EUC groups (mean = 29.7 vs. 30.0 minutes; P > 0.05). BREASTChoice had high usability (mean score = 6.3/7). Participants completed BREASTChoice in about 27 minutes. CONCLUSIONS: BREASTChoice can improve breast reconstruction decision quality by improving patients' knowledge and providing them with personalized risk estimates. More research is needed to facilitate point-of-care decision support and examine BREASTChoice's impact on patients' decisions over time.
引用
- Politi MC, Lee CN, Philpott-Streiff SE, et al. A Randomized Controlled Trial Evaluating the BREASTChoice Tool for Personalized Decision Support About Breast Reconstruction After Mastectomy. Ann Surg. 2020. PMID: 31305282. doi:10.1097/SLA.0000000000003444
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。